BIAL - Portela & Cª, S.A.

Tweet this page
<
2023
2024
>
Registration as it was on 05 Feb 2024
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

25,000€ - 49,999€

Financial year: Jan 2023 - Dec 2023

Lobbyists (Full time equivalent)

0.35 Fte (2)

Lobbyists with EP accreditation

0

High-level Commission meetings

0

Lobbying Costs over the years

  • Info

    BIAL - Portela & Cª, S.A.   (BIAL)

    EU Transparency Register

    013596348877-66 First registered on 02 Feb 2023

    Goals / Remit

    BIAL is an innovative pharmaceutical company. Dedicated to discovering, developing and commercializing medicines, we are committed to improve people’s lives worldwide. Keeping life in mind.
    BIAL’s mission is to discover, develop and provide therapeutic solutions within the area of health.
    We have as strategic lines the Quality, the Research and Development and the Internationalisation.
    We provide solutions for people’s health needs, by playing an active role in the global economy. We also aim to contribute to the construction of a knowledgeable society, one that is competitive, operates with utmost integrity and dynamic, based on scientific development and innovation.
    The values that guide us reflect our identity are: Caring for Health, Invest in Quality and Innovation, Excellence in scientific research, Integrity and high standards of ethics, Rigour, responsibility and teamwork and Respect for the universal values

    Main EU files targeted

    European Pharmaceutical Strategy, EU Pharmaceutical Legislation, EU Health Technology Assessment, European Health Data Space and Clinical Trials Directive

    Address

    Head Office
    A Av. da Siderugia Nacional
    Coronado 4745-457 - 4745-457
    PORTUGAL
    EU Office
    A Av. da Siderugia Nacional
    Coronado 4745-457 - 4745-457
    PORTUGAL

    Website

  • People

    Total lobbyists declared

    2

    Employment timeLobbyists
    25%1
    10%1

    Lobbyists (Full time equivalent)

    0.35

    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Companies & groups

  • Networking

    Affiliation

    Efpia, Apifarma, United Global Compact, Business Roundtable Portugal, Health Cluster Portugal, AEP, CIP

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2023 - Dec 2023

    Lobbying costs for closed financial year

    25,000€ - 49,999€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    None declared

    Intermediaries for current year

    None declared

    Closed year Costs

    25,000€ - 49,999€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    N/A

    Communication activities

    None

    Other activities

    None declared

  • Meetings

    Meetings

    None declared

Download this datacard